Literature DB >> 29302777

Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.

Drew Pratt1, Siva Kumar Natarajan1, Adam Banda1, Caterina Giannini2, Pankaj Vats3, Carl Koschmann4, Rajen Mody4, Arul Chinnaiyan3, Sriram Venneti5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29302777      PMCID: PMC6018022          DOI: 10.1007/s00401-018-1805-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  4 in total

1.  Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours.

Authors:  Anh Tuan Nguyen; Carole Colin; Isabelle Nanni-Metellus; Laetitia Padovani; Claude-Alain Maurage; Pascale Varlet; Catherine Miquel; Emmanuelle Uro-Coste; Catherine Godfraind; Emmanuelle Lechapt-Zalcman; François Labrousse; Guillaume Gauchotte; Karen Silva; Anne Jouvet; Dominique Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04       Impact factor: 8.090

2.  H3 K27M Mutation in Gangliogliomas can be Associated with Poor Prognosis.

Authors:  B K Kleinschmidt-DeMasters; Andrew Donson; Nicholas K Foreman; Kathleen Dorris
Journal:  Brain Pathol       Date:  2017-04-05       Impact factor: 6.508

3.  Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.

Authors:  Mélanie Pagès; Kevin Beccaria; Nathalie Boddaert; Raphaël Saffroy; Aurore Besnard; David Castel; Frédéric Fina; Doriane Barets; Emilie Barret; Ludovic Lacroix; Franck Bielle; Felipe Andreiuolo; Arnault Tauziède-Espariat; Dominique Figarella-Branger; Stéphanie Puget; Jacques Grill; Fabrice Chrétien; Pascale Varlet
Journal:  Brain Pathol       Date:  2017-02-08       Impact factor: 6.508

4.  Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation.

Authors:  Cordelia Orillac; Cheddhi Thomas; Yosef Dastagirzada; Eveline Teresa Hidalgo; John G Golfinos; David Zagzag; Jeffrey H Wisoff; Matthias A Karajannis; Matija Snuderl
Journal:  Acta Neuropathol Commun       Date:  2016-08-12       Impact factor: 7.801

  4 in total
  12 in total

Review 1.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

2.  Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.

Authors:  Fausto J Rodriguez; Jacqueline A Brosnan-Cashman; Sariah J Allen; M Adelita Vizcaino; Caterina Giannini; Sandra Camelo-Piragua; Milad Webb; Marcus Matsushita; Nitin Wadhwani; Abeer Tabbarah; Dima Hamideh; Liqun Jiang; Liam Chen; Leonidas D Arvanitis; Hussein H Alnajar; John R Barber; Alicia Rodríguez-Velasco; Brent Orr; Christopher M Heaphy
Journal:  Brain Pathol       Date:  2018-10-17       Impact factor: 6.508

Review 3.  Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.

Authors:  Kyle Wierzbicki; Karthik Ravi; Andrea Franson; Amy Bruzek; Evan Cantor; Micah Harris; Morgan J Homan; Bernard L Marini; Abed Rahman Kawakibi; Ramya Ravindran; Rodrigo Teodoro; Viveka Nand Yadav; Carl Koschmann
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

4.  Genetic signature and treatment of pediatric high-grade glioma.

Authors:  Milena Guidi; Laura Giunti; Anna Maria Buccoliero; Chiara Caporalini; Maria Luigia Censullo; Luisa Galli; Lorenzo Genitori; Iacopo Sardi
Journal:  Mol Clin Oncol       Date:  2021-02-12

5.  Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.

Authors:  Margot A Lazow; Christine Fuller; Mariko DeWire; Adam Lane; Pratiti Bandopadhayay; Ute Bartels; Eric Bouffet; Sylvia Cheng; Kenneth J Cohen; Tabitha M Cooney; Scott L Coven; Hetal Dholaria; Blanca Diez; Kathleen Dorris; Moatasem El-Ayadi; Ayman El-Sheikh; Paul G Fisher; Adriana Fonseca; Mercedes Garcia Lombardi; Robert J Greiner; Stewart Goldman; Nicholas Gottardo; Sridharan Gururangan; Jordan R Hansford; Tim Hassall; Cynthia Hawkins; Lindsay Kilburn; Carl Koschmann; Sarah E Leary; Jie Ma; Jane E Minturn; Michelle Monje-Deisseroth; Roger Packer; Yvan Samson; Eric S Sandler; Gustavo Sevlever; Christopher L Tinkle; Karen Tsui; Lars M Wagner; Mohamed Zaghloul; David S Ziegler; Brooklyn Chaney; Katie Black; Anthony Asher; Rachid Drissi; Maryam Fouladi; Blaise V Jones; James L Leach
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

Review 6.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

7.  Recent Progress in the Pathology and Genetics of Pilocytic and Pilomyxoid Astrocytomas

Authors:  Cristine Ding; Tarik Tihan
Journal:  Balkan Med J       Date:  2018-07-09       Impact factor: 2.021

8.  Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study.

Authors:  Yuan Wang; Lan-Lan Feng; Pei-Gang Ji; Jing-Hui Liu; Shao-Chun Guo; Yu-Long Zhai; Eric W Sankey; Yue Wang; Yan-Rong Xue; Na Wang; Miao Lou; Meng Xu; Min Chao; Guo-Dong Gao; Yan Qu; Li Gong; Liang Wang
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

9.  Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients.

Authors:  Hainan Li; Changguo Shan; Shengnan Wu; Baijie Cheng; Chongzu Fan; Linbo Cai; Yedan Chen; Yuqian Shi; Kaihua Liu; Yang Shao; Dan Zhu; Zhi Li
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

10.  Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.

Authors:  Tina Huang; Roxanna Garcia; Jin Qi; Rishi Lulla; Craig Horbinski; Amir Behdad; Nitin Wadhwani; Ali Shilatifard; Charles James; Amanda M Saratsis
Journal:  Oncotarget       Date:  2018-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.